1JONES RN. Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins [J]. Am J Health Syst Pharm,1995,52(6 Suppl 2) :S29-S33.
2DELEY D, MULGRAVE L, MUNRO R, et al. An evaluation of the in vitro activity of piperacilin/tazobactam [J ]. Pathology,1996,28(2):167-172.
3BRYSON HM, BROGDEN RN. Piperacilin/tazobactam: a review of its antibacterial activity, pharmacokinetic properties and the rapeutic potential [J]. Drugs, 1994,47(3):506-535.
4SANDERS CC. Chromosomal cephalosporinases responsible for,multiple resistance to newer β-lactam antibiotics [J ]. Ann Rev Microbiol, 1987,41(3) :573-593.
5SNDERS WE JR, SANDERS CC. Piperacacillin/tazobactam: a critical review of the evolving clinical literature [J ]. Clin Infer Dis,1996,22( 1 ) : 107-123.
